Nat West Group PLC Johnson & Johnson Transaction History

Nat West Group PLC

$338 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$154.35 - $166.11 $375,224 - $403,813	2,431 New	2,431 $402,000
Q2 2022 Jul 20, 2022	SELL	$168.19 - $186.01 $44,738 - $49,478	-266 Reduced 14.04%	1,628 $289,000
Q1 2022 May 03, 2022	SELL	$158.14 - $179.59 $224,558 - $255,017	-1,420 Reduced 42.85%	1,894 $336,000
Q4 2021 Feb 07, 2022	SELL	$155.93 - $173.01 $1.11 Million - $1.23 Million	-7,110 Reduced 68.21%	3,314 $567,000
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $182,818 - $203,160	-1,132 Reduced 9.8%	10,424 $1.68 Million
Q2 2021 Jul 21, 2021	SELL	$159.48 - $171.07 $207,483 - $222,562	-1,301 Reduced 10.12%	11,556 $1.9 Million
Q1 2021 Apr 16, 2021	SELL	$153.07 - $170.48 $364,000 - $405,401	-2,378 Reduced 15.61%	12,857 $2.11 Million
Q4 2020 Feb 04, 2021	SELL	$137.11 - $157.38 $667,725 - $766,440	-4,870 Reduced 24.22%	15,235 $2.4 Million
Q3 2020 Nov 10, 2020	SELL	$140.38 - $153.83 $167,613 - $183,673	-1,194 Reduced 5.61%	20,105 $2.99 Million
Q2 2020 Jul 16, 2020	SELL	$128.81 - $155.51 $144,009 - $173,860	-1,118 Reduced 4.99%	21,299 $3 Million
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $35,009 - $48,506	-315 Reduced 1.39%	22,417 $2.94 Million
Q4 2019 Feb 06, 2020	SELL	$127.5 - $146.44 $14 Million - $16.1 Million	-109,699 Reduced 82.83%	22,732 $3.32 Million
Q3 2019 Oct 24, 2019	SELL	$126.95 - $142.14 $6.86 Million - $7.68 Million	-54,024 Reduced 28.97%	132,431 $17.1 Million
Q2 2019 Jul 25, 2019	BUY	$131.15 - $144.24 $2.47 Million - $2.72 Million	18,849 Added 11.25%	186,455 $26 Million
Q1 2019 May 08, 2019	BUY	$125.72 - $139.79 $1.27 Million - $1.41 Million	10,096 Added 6.41%	167,606 $23.4 Million
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $18.3 Million - $22 Million	149,078 Added 1768.0%	157,510 $20.3 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $1.24 Million - $1.45 Million	-10,180 Reduced 54.7%	8,432 $1.17 Million
Q2 2018 Aug 13, 2018	SELL	$119.4 - $131.76 $73,431 - $81,032	-615 Reduced 3.2%	18,612 $2.26 Million
Q4 2017 Feb 06, 2018	SELL	$131.22 - $143.62 $250,630 - $274,314	-1,910 Reduced 9.04%	19,227 $2.69 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,137	21,137 $2.8 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nat West Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Nat West Group PLC with notifications on news.

Account